Research and Markets: New Report Examines the CepTor Corp Product Pipeline
Posted on: Friday, 23 November 2007, 12:00 CST
Research and Markets (http://www.researchandmarkets.com/reports/c75128) has announced the addition of CepTor Corp - Product Pipeline Report to their offering.
The CepTor Corp Latest Product Pipeline Report contains contact information, business summary, company details, selected financial data, detailed product pipeline (including disease hub, description, therapeutic indication, mechanism of action, drug class, current trial information, trial details and partnering detail), product revenue, trademarks, corporate partners and management profiles.
Our products provide an unbiased, accurate, independent approach to company analysis, whether for partnering or investment purposes. They are based on the most comprehensive database of private and public biomedical companies available.
Updated daily, the database covers 8,000 companies, over 24,000 products across 17 therapeutic categories with 700 sub-categories. We distil and systematize pipeline, financial, competitive product, mechanism of action, partnering, and patent information to provide the most comprehensive and up-to-date information available. The CepTor Corp Product Pipeline Report therefore delivers the latest and the most comprehensive intelligence available on CepTor Corps current pipeline portfolio.
Product Pipeline Reports
Business Summary
Contact Information
Selected Financial Data
Company Details
Product Glance (Table/Graph)
Disease Hub Classification (Table/Graph)
Product Pipeline
Product Catalog
Product Details with Description, Therapeutic Indication, Drug Class, Mechanism of Action, Current Trial, Trial Details, Partnering Details etc.
Patent Details (if any)
Recent Financings
Trademarks
Deals & Alliances
Management Profile
Recent Updates
For more information visit http://www.researchandmarkets.com/reports/c75128.
Source: Life Science Analytics
Source: Business Wire
Related Articles
- Research and Markets: Gain Insight Into the Current Product Pipeline at Vyteris Holdings (Nevada) Inc With Comprehensive Report
- Pain Therapeutics Inc Product Pipeline Report Is Based On The Most Comprehensive Database Of Private And Public Biomedical Companies Available
- Research and Markets: 3M Company Product Pipeline Report Offers Key Company Details and Data for New Business and Competitors
- The Oncolytics Biotech Inc. Product Pipeline Report Delivers the Latest and the Most Comprehensive Intelligence Available on Oncolytics Biotech Inc.'s Current Pipeline Portfolio
- Research and Markets: Lexicon Genetics Incorporated - Product Pipeline Report Provides Product Details With Description, Therapeutic Indication, Drug Class, Mechanism of Action, Current Trial, Trial Details and Partnering Details
- Research and Markets: the New Generex Biotechnology Corporation Latest Product Pipeline Report Contains Contact Information, Business Summary, Company Details and Selected Financial Data
- Research and Markets: Manhattan Pharmaceuticals Inc New - Detailed Product Pipeline Report Available Now
- Research and Markets: The Labopharm Inc Latest Product Pipeline Report Contains Contact Information, Business Summary, Company Details And Selected Financial Data
- Axonyx Reports Phenserine Associated With Significant Amyloid Reduction in Phase I Trial; Results Support Dual Mechanisms of Action
 |
 |
User Comments (0)
RSS Feeds